Lantern Pharma Inc’s recently made public that its 10% Owner Kreis Leslie W. unloaded Company’s shares for reported $95954.0 on Feb 29 ’24. In the deal valued at $4.87 per share,19,703 shares were sold. As a result of this transaction, Kreis Leslie W. now holds 60,256 shares worth roughly $0.47 million.
Then, Fletcher Aaron G.L. sold 19,703 shares, generating $95,954 in total proceeds. Upon selling the shares at $4.87, the 10% Owner now owns 60,256 shares.
Before that, Fletcher Aaron G.L. sold 74,297 shares. Lantern Pharma Inc shares valued at $360,340 were divested by the 10% Owner at a price of $4.85 per share. As a result of the transaction, Fletcher Aaron G.L. now holds 62,088 shares, worth roughly $0.48 million.
H.C. Wainwright initiated its Lantern Pharma Inc [LTRN] rating to a Buy in a research note published on October 07, 2021; the price target was $32.
Price Performance Review of LTRN
On Tuesday, Lantern Pharma Inc [NASDAQ:LTRN] saw its stock fall -0.39% to $7.76. Over the last five days, the stock has lost -15.19%. Lantern Pharma Inc shares have risen nearly 81.31% since the year began. Nevertheless, the stocks have risen 51.56% over the past one year. While a 52-week high of $11.99 was reached on 03/25/24, a 52-week low of $2.38 was recorded on 01/17/24. SMA at 50 days reached $6.20, while 200 days put it at $4.62. A total of 0.24 million shares were traded, compared to the trading of 0.58 million shares in the previous session.
Levels Of Support And Resistance For LTRN Stock
The 24-hour chart illustrates a support level at 7.42, which if violated will result in even more drops to 7.09. On the upside, there is a resistance level at 8.18. A further resistance level may holdings at 8.61. The Relative Strength Index (RSI) on the 14-day chart is 50.02, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.15, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 86.86%. Stochastics %K at 13.35% indicates the stock is a buying.
How much short interest is there in Lantern Pharma Inc?
A steep rise in short interest was recorded in Lantern Pharma Inc stocks on Mar 15, 2024, growing by 85000.0 shares to a total of 0.14 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 59560.0 shares. There was a rise of 58.8%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.58% of the overall stock float, the days-to-cover ratio (short ratio) rose to 0.3.
